Mohamed Mahmoud Dogha

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Benign Prostatic Hyperplasia

Mesenchymal Stem Cells

Lower Urinary Tract Symptoms

Top Venues

World journal of urology

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed Mahmoud Dogha, Hossam Shaker, Assem Abdelazeez, Ahmed Abd-El Latif, Mahmoud S ElAdawy
Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention. World journal of urology 42 (1) (2024)
Mohamed Mahmoud Dogha, Hossam Shaker, Assem Abdelazeez, Ahmed Abd-El Latif, Mahmoud S ElAdawy
Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention. World journal of urology 42 (1) (2024)
Mohamed Mahmoud Dogha, Hossam Shaker, Assem Abdelazeez, Ahmed Abd-El Latif, Mahmoud S ElAdawy
Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention. World journal of urology 42 (1) (2024)
Mohamed Mahmoud Dogha, Hossam Shaker, Assem Abdelazeez, Ahmed Abd-El Latif, Mahmoud S ElAdawy
Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention. World journal of urology 42 (1) (2024)
Mohamed Mahmoud Dogha, Hossam Shaker, Assem Abdelazeez, Ahmed Abd-El Latif, Mahmoud S ElAdawy
Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention. World journal of urology 42 (1) (2024)
Mohamed Mahmoud Dogha, Hossam Shaker, Assem Abdelazeez, Ahmed Abd-El Latif, Mahmoud S ElAdawy
Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention. World journal of urology 42 (1) (2024)
Mohamed Mahmoud Dogha, Hossam Shaker, Assem Abdelazeez, Ahmed Abd-El Latif, Mahmoud S ElAdawy
Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention. World journal of urology 42 (1) (2024)
Mohamed Mahmoud Dogha, Hossam Shaker, Assem Abdelazeez, Ahmed Abd-El Latif, Mahmoud S ElAdawy
Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention. World journal of urology 42 (1) (2024)
Mohamed Mahmoud Dogha, Hossam Shaker, Assem Abdelazeez, Ahmed Abd-El Latif, Mahmoud S ElAdawy
Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention. World journal of urology 42 (1) (2024)